EVOLIS MICROPLATE SYSTEM
Report
- Report Number
- 3022521-2011-00003
- Event Type
- Other
- Date Received
- September 21, 2011
- Date of Event
- August 23, 2011
- Report Date
- September 21, 2011
- Manufacturer
- BIO-RAD LABORATORIES, INC.
- Product Code
- LOL
- PMA / PMN Number
- K092353
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TX, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
ON (B)(6) 2011, A CUSTOMER CONTACTED THE BIO-RAD LABORATORIES TECHNICAL SUPPORT DEPARTMENT TO REQUEST HELP IN INTERPRETING A RESULT FROM A PT SAMPLE WHEN RUNNING THE BIO-RAD TOXOPLASMA IGG EIA ASSAY, ON THE EVOLIS MICROPLATE SYSTEM. THE EVOLIS IS A 4-PLATE SELF-CONTAINED MICROPLATE PROCESSOR SYSTEM DESIGNED FOR USE WITH EIA ASSAYS. THE CUSTOMER REPORTED THE PT SAMPLE RESULT VALUE WAS HIGHER THAN THE TOXOPLASMA IGG CALIBRATOR 1 VALUE FOR THE ASSAY BUT THE RESULT REPORTED WAS NEGATIVE. THE CUSTOMER STATED THAT A PREVIOUS PT SAMPLE VALUE WAS HIGHER THAN THE TOXOPLASMA IGG CALIBRATOR 1 VALVE BUT THE REPORTED RESULT WAS POSITIVE. TECHNICAL SUPPORT REVIEWED THE DATA SENT BY THE CUSTOMER AND DISCOVERED THAT THE CUSTOMER HAD ENTERED INCORRECT VALUES FOR THE MINIMUM AND MAXIMUM POSITIVE CONTROL TOXOPLASMA IGG CALIBRATOR 1, AND TOXOPLASMA IGG CALIBRATOR 2. THE CUSTOMER ENTERED THE INDEX VALUES INSTEAD OF THE IU/ML AS STATED IN THE EVOLIS MATRM FOR THE TOXOPLASMA IGG EIA ASSAY. TECHNICAL SUPPORT INFORMED THE CUSTOMER THE VALUES ENTERED WERE INCORRECT AND INSTRUCTED THE CUSTOMER TO FOLLOW THE MATRM; WHICH TELLS THE CUSTOMER WHAT SHOULD BE ENTERED. TECHNICAL SUPPORT REQUESTED PREVIOUS RUN DATA FOR REVIEW TO SEE IF THE ERROR OCCURRED IN PREVIOUS RUNS. THE REVIEW OF THE DATA SHOWED 4 PT SAMPLES WHICH SHOULD HAVE BEEN REPORTED AS POSITIVE WERE REPORTED AS NEGATIVE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | EVOLIS MICROPLATE SYSTEM | 4 PS (FOUR PLATE SYSTEM) | LOL | BIO-RAD LABORATORIES, INC. | EVOLIS |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |